| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.21B | 15.24B | 17.57B | 14.47B | 10.67B | 9.00B |
| Gross Profit | 4.63B | 4.39B | 5.60B | 4.55B | 3.52B | 3.09B |
| EBITDA | 1.97B | 1.50B | 2.51B | 1.67B | 883.00M | 595.00M |
| Net Income | 1.20B | 979.00M | 1.77B | 1.35B | 865.00M | 670.00M |
Balance Sheet | ||||||
| Total Assets | 15.10B | 15.04B | 15.57B | 13.88B | 12.27B | 11.13B |
| Cash, Cash Equivalents and Short-Term Investments | 5.66B | 6.60B | 9.82B | 10.71B | 9.10B | 7.91B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.79B | 2.03B | 2.69B | 2.19B | 1.65B | 1.06B |
| Stockholders Equity | 13.20B | 12.91B | 12.79B | 11.62B | 10.58B | 10.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.61B | 545.00M | 1.80B | 1.59B | 368.00M |
| Operating Cash Flow | 0.00 | -1.51B | 653.00M | 1.89B | 1.62B | 379.00M |
| Investing Cash Flow | 0.00 | -827.00M | -811.00M | 135.00M | -157.00M | 22.00M |
| Financing Cash Flow | 0.00 | -873.00M | -755.00M | -408.00M | -308.00M | -560.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥12.78B | 12.00 | 11.46% | 4.65% | 20.51% | 66.82% | |
79 Outperform | ¥49.56B | 67.26 | 14.31% | 1.36% | 18.44% | 26.68% | |
75 Outperform | ¥41.04B | 9.78 | ― | 3.02% | 7.09% | 13.13% | |
66 Neutral | ¥85.63B | 8.78 | ― | 2.41% | 16.05% | 3.58% | |
64 Neutral | ¥438.96B | 14.59 | ― | 2.87% | 8.99% | -43.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥12.73B | 13.17 | ― | 3.70% | -10.61% | -18.70% |